logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/08/2025
Market news: Gildan is close to reaching a deal to acquire lingerie manufacturer Hanesbrands, valuing the latter at $5 billion.
Latest
2 m ago
At the investment strategy conference hosted by JD Finance, Zhao Bei, Co-General Manager of Industrial Bank Research Department, stated that the current total scale of innovative drugs in China is between 200 billion and 300 billion yuan, with huge market potential in the future. In the past decade, policies have comprehensively supported the development of the innovative drug industry. China has become the global center for the research and development of innovative drugs. In the products authorized to enter the U.S. market, 23% already come from Chinese pharmaceutical companies, and this proportion has been increasing year by year over the past 5 years. MNCs in Europe and America are also facing a large number of expiring patents and urgently need more products to supplement their pipelines. There is hope for an increase in opportunities for Chinese innovative drugs to go global.
3 m ago
Mass production speeds up, revenue growth strong! Pony.ai's seventh generation Robotaxi production offline exceeds 200 units, passenger fare revenue in the second quarter triples.
4 m ago
"603739.SH Azure Biosciences was awarded a new animal drug registration certificate."
4 m ago
Dingtong Technology: The company's liquid cooling products have been shipped in small batches.
5 m ago
Tax increase impact weaker than expected! UK July employment data unexpectedly narrowed, central bank interest rate cuts balance once again sways.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.